• Explore /
  • Poster
  • / Baseline circulating soluble factors as predictors of response to nivolumab in metastatic clear cell renal cell carcinoma (mRCC): A validation study within the NIVOREN GETUG-AFU 26 translational study.

Baseline circulating soluble factors as predictors of response to nivolumab in metastatic clear cell renal cell carcinoma (mRCC): A validation study within the NIVOREN GETUG-AFU 26 translational study.

Abstract Poster

Authors

null

Lucia Carril-Ajuria

Gustave Roussy, Villejuif, France

Lucia Carril-Ajuria , Marie Naigeon , Cécile Dalban , Aude Desnoyer , Nathalie Rioux-Leclercq , Catherine Sautes-Fridman , Maxime Meylan , Yann-Alexandre Vano , Benoit Beusenlick , Salem Chouaib , Caroline de Oliveira , Florence Tantot , Ronan Flippot , Bernard Escudier , Laurence Albiges , Nathalie Chaput

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 4552)

DOI

10.1200/JCO.2022.40.16_suppl.4552

Abstract #

4552

Poster Bd #

43

Abstract Disclosures

Similar Posters

First Author: Lucia Carril-Ajuria

First Author: Fengnian Zhao

First Author: Thomas Hilser

First Author: Lucia Carril